Seamus Fernandez

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Seamus Fernandez works at GUGGENHEIM and is focused on the Healthcare sector with 239 price targets and ratings documented since 2013 spanning on 14 stocks. Previously, Seamus Fernandez worked at LEERINK. Analyst's average stock valuation to be materialised ratio is 69.89% with an average time for price targets to be met of 495.93 days.

Most recent stock forecast was given on ALBO, Albireo Pharma, Inc at 11-Jan-2023.

Seamus Fernandez best performing recommendations are on ADGI.
The best stock recommendation documented was for VIE at 1/7/2020. The price target of $45 was fulfilled within 9 days with a profit of $17.12 (61.41%) receiving and performance score of 68.23.

Average potential price target upside

of $24.72 (42.73%) on NVS (NOVARTIS AG).
of $24.21 (30.01%) on LLY (ELI LILLY AND COMPANY).
of $20.77 (26.95%) on ZLAB (ZAI LAB LIMITED).

Currently, out of the existing stock ratings of Seamus Fernandez - 12051 which are a Buy (67.77%), 5598 which are a Hold (31.48%), 132 which are a Sell (0.74%)